Historic CRISPR drug approval heralds new era in Cas9 IP wars
Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.
Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.
Chief Legal Officer Yoori Kim argues that current patent uncertainty should fuel rather than thwart licensing deals
The surge is due to 9,702 US patent assets involved in the BlackBerry sale to Key Patent Innovations, which runs Malikie Innovations, according to the AST Patent Deals Report for Q2 2023
25 March 2021
25 March 2021
25 March 2021
25 March 2021
Unlock unlimited access to all IAM content